AGRX - Agile Therapeutics, Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Dec 2017)Next Qtr. (Mar 2018)Current Year (2017)Next Year (2018)
No. of Analysts5255
Avg. Estimate-0.24-0.26-0.97-0.85
Low Estimate-0.27-0.28-1.02-1.16
High Estimate-0.22-0.23-0.91-0.57
Year Ago EPS-0.29-0.26-1.13-0.97
Revenue EstimateCurrent Qtr. (Dec 2017)Next Qtr. (Mar 2018)Current Year (2017)Next Year (2018)
No. of Analysts6266
Avg. EstimateN/AN/AN/A8.44M
Low EstimateN/AN/AN/AN/A
High EstimateN/AN/AN/A33M
Year Ago SalesN/AN/AN/AN/A
Sales Growth (year/est)N/AN/AN/AN/A
Earnings History12/30/20163/30/20176/29/20179/29/2017
EPS Est.-0.28-0.3-0.28-0.24
EPS Actual-0.29-0.26-0.26-0.22
Difference-0.010.040.020.02
Surprise %-3.60%13.30%7.10%8.30%
EPS TrendCurrent Qtr. (Dec 2017)Next Qtr. (Mar 2018)Current Year (2017)Next Year (2018)
Current Estimate-0.24-0.26-0.97-0.85
7 Days Ago-0.24-0.26-0.97-0.85
30 Days Ago-0.24-0.55-0.98-0.88
60 Days Ago-0.24-0.55-0.98-1.07
90 Days Ago-0.26-0.49-1.02-0.98
EPS RevisionsCurrent Qtr. (Dec 2017)Next Qtr. (Mar 2018)Current Year (2017)Next Year (2018)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 Days1123
Down Last 30 DaysN/AN/AN/AN/A
Down Last 90 DaysN/AN/AN/AN/A
Growth EstimatesAGRXIndustrySectorS&P 500
Current Qtr.17.20%N/AN/A0.26
Next Qtr.N/AN/AN/A0.34
Current Year14.20%N/AN/A0.09
Next Year12.40%N/AN/A0.15
Next 5 Years (per annum)N/AN/AN/A0.11
Past 5 Years (per annum)N/AN/AN/AN/A